New hope for Hard-to-Treat cancers: experimental drug E303 enters human trials
Disease control
Recruiting now
This early-stage trial tests an experimental drug called E303 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. The main goals are to check safety and see if the …
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 17, 2026 01:27 UTC